Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Participants With Untreated Extensive-Stage Small Cell Lung Cancer
Clinical trial NCT04665856 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04665856
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-21
- Primary completion
- 2023-08-31
- Enrollment
- 123
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.